These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1748397)

  • 1. Increased levels of circulating interleukin-6 in patients with Hodgkin's disease.
    Gause A; Scholz R; Klein S; Jung W; Diehl V; Tesch H; Hasenclever D; Pfreundschuh M
    Hematol Oncol; 1991; 9(6):307-13. PubMed ID: 1748397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum interleukin 6 levels are elevated in lymphoma patients and correlate with survival in advanced Hodgkin's disease and with B symptoms.
    Kurzrock R; Redman J; Cabanillas F; Jones D; Rothberg J; Talpaz M
    Cancer Res; 1993 May; 53(9):2118-22. PubMed ID: 8481913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical correlates of elevated serum levels of interleukin 6 in patients with untreated Hodgkin's disease.
    Seymour JF; Talpaz M; Hagemeister FB; Cabanillas F; Kurzrock R
    Am J Med; 1997 Jan; 102(1):21-8. PubMed ID: 9209197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased levels of circulating cytokines in patients with untreated Hodgkin's disease.
    Gause A; Keymis S; Scholz R; Schobert I; Jung W; Diehl V; Pohl C; Pfreundschuh M
    Lymphokine Cytokine Res; 1992 Apr; 11(2):109-13. PubMed ID: 1581417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-6, but not interleukin-4, is expressed by Reed-Sternberg cells in Hodgkin's disease with or without histologic features of Castleman's disease.
    Hsu SM; Xie SS; Hsu PL; Waldron JA
    Am J Pathol; 1992 Jul; 141(1):129-38. PubMed ID: 1632458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum concentrations of cytokines in patients with Hodgkin's disease.
    Blay JY; Farcet JP; Lavaud A; Radoux D; Chouaïb S
    Eur J Cancer; 1994; 30A(3):321-4. PubMed ID: 8204352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased serum levels of interleukin-9 correlate to negative prognostic factors in Hodgkin's lymphoma.
    Fischer M; Bijman M; Molin D; Cormont F; Uyttenhove C; van Snick J; Sundström C; Enblad G; Nilsson G
    Leukemia; 2003 Dec; 17(12):2513-6. PubMed ID: 14562126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-invasive detection of genomic imbalances in Hodgkin/Reed-Sternberg cells in early and advanced stage Hodgkin's lymphoma by sequencing of circulating cell-free DNA: a technical proof-of-principle study.
    Vandenberghe P; Wlodarska I; Tousseyn T; Dehaspe L; Dierickx D; Verheecke M; Uyttebroeck A; Bechter O; Delforge M; Vandecaveye V; Brison N; Verhoef GE; Legius E; Amant F; Vermeesch JR
    Lancet Haematol; 2015 Feb; 2(2):e55-65. PubMed ID: 26687610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poor clinical outcome of patients with Hodgkin's disease and elevated interleukin-10 serum levels. Clinical significance of interleukin-10 serum levels for Hodgkin's disease.
    Bohlen H; Kessler M; Sextro M; Diehl V; Tesch H
    Ann Hematol; 2000 Mar; 79(3):110-3. PubMed ID: 10803931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Differential diagnostic and prognostic value of serum cytokines (soluble CD30, soluble interleukin-2 receptor, interleukin-10 and interleukin-6) in Hodgkin's disease and lymphosarcomas].
    Iaguzhinskaia OE; Lazarev IE; Nikitin EA; Samoĭlova RS; Loginova IV; Gemdzhan EG; Novikov VA; Mamiliaeva ZKh; Pivnik AV
    Ter Arkh; 2001; 73(4):45-51. PubMed ID: 11494447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokine production (IL-1 alpha, IL-1 beta, and TNF alpha) and endothelial cell activation (ELAM-1 and HLA-DR) in reactive lymphadenitis, Hodgkin's disease, and in non-Hodgkin's lymphomas. An immunocytochemical study.
    Ruco LP; Pomponi D; Pigott R; Stoppacciaro A; Monardo F; Uccini S; Boraschi D; Tagliabue A; Santoni A; Dejana E
    Am J Pathol; 1990 Nov; 137(5):1163-71. PubMed ID: 1700619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum cytokine levels correlate with clinical parameters in Hodgkin's disease.
    Gorschlüter M; Bohlen H; Hasenclever D; Diehl V; Tesch H
    Ann Oncol; 1995 May; 6(5):477-82. PubMed ID: 7545429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-10 levels are often elevated in serum of adults with Hodgkin's disease and are associated with inferior failure-free survival.
    Sarris AH; Kliche KO; Pethambaram P; Preti A; Tucker S; Jackow C; Messina O; Pugh W; Hagemeister FB; McLaughlin P; Rodriguez MA; Romaguera J; Fritsche H; Witzig T; Duvic M; Andreeff M; Cabanillas F
    Ann Oncol; 1999 Apr; 10(4):433-40. PubMed ID: 10370786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hodgkin's disease and non-Hodgkin's lymphoma containing Reed-Sternberg-like giant cells in Taiwan. A clinicopathologic analysis of 50 cases.
    Hong RL; Su IJ; Chen YC; Hsieh HC; Wang CH; Liu CH; Shen MC
    Cancer; 1992 Mar; 69(5):1254-8. PubMed ID: 1739924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High serum interleukin-6 levels correlate with a shorter failure-free survival in indolent lymphoma.
    Fayad L; Cabanillas F; Talpaz M; McLaughlin P; Kurzrock R
    Leuk Lymphoma; 1998 Aug; 30(5-6):563-71. PubMed ID: 9711918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hodgkin and Reed-Sternberg cells express interleukin 6 and interleukin 6 receptors.
    Tesch H; Jücker M; Klein S; Abts H; Günther A; Krueger GR; Diehl V
    Leuk Lymphoma; 1992 Jul; 7(4):297-303. PubMed ID: 1493429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin 6 expression by Hodgkin/Reed-Sternberg cells is associated with the presence of 'B' symptoms and failure to achieve complete remission in patients with advanced Hodgkin's disease.
    Reynolds GM; Billingham LJ; Gray LJ; Flavell JR; Najafipour S; Crocker J; Nelson P; Young LS; Murray PG
    Br J Haematol; 2002 Jul; 118(1):195-201. PubMed ID: 12100148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Composite lymphoma. A clinicopathologic analysis of nine patients with Hodgkin's disease and B-cell non-Hodgkin's lymphoma.
    Gonzalez CL; Medeiros LJ; Jaffe ES
    Am J Clin Pathol; 1991 Jul; 96(1):81-9. PubMed ID: 2069139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphological and immunohistochemical investigation of non-Hodgkin's lymphoma combined with Hodgkin's disease.
    Hansmann ML; Fellbaum C; Hui PK; Lennert K
    Histopathology; 1989 Jul; 15(1):35-48. PubMed ID: 2548946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abundant expression of transforming growth factor-beta 1 and -beta 2 by Hodgkin's Reed-Sternberg cells and by reactive T lymphocytes in Hodgkin's disease.
    Hsu SM; Lin J; Xie SS; Hsu PL; Rich S
    Hum Pathol; 1993 Mar; 24(3):249-55. PubMed ID: 7681031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.